ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/13/2024
Back to search
Official data from USPTO
ABYLQIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
14
Latest update
01/10/2025
Classification
Registered
Trademark type
Word
Nice classes
5, 10
Filing date
11/26/2020
Registration date
09/07/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/07/2021
Last transaction
01/10/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
FR
Examiner
HISER, CHARLES
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
D. T. (pessoa física)
Representatives
REGIMBEAU
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Adhesive patches for cutaneous or epicutaneous administration of powdered medical or pharmaceutical substances for human use for allergy treatment; patch containing a powdered preparation for medical use for allergy treatment; occlusive patch for cutaneous absorption of powdered medical substances for allergy treatment; all the aforesaid goods only for human use
Class 10
Medical instrumentsapparatus and devices for cutaneous or epicutaneous administration of powdered medical or cosmetic substances for human use for allergy treatment; medical instrument using the electrostatic properties of a biocompatible medium for allergy treatment; all the aforesaid goods only for human use
Publications
History of USPTO decisions and trademark events.
14 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/15/2024
GPNX
NOTIFICATION PROCESSED BY IB
11/28/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/10/2021
FIMP
FINAL DISPOSITION PROCESSED
11/10/2021
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
10/07/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
09/07/2021
PUBO
PUBLISHED FOR OPPOSITION
06/22/2021
NPUB
NOTICE OF PUBLICATION
06/02/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/17/2021
DOCK
ASSIGNED TO EXAMINER
05/12/2021
MAFR
APPLICATION FILING RECEIPT MAILED
02/02/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/29/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/28/2021
Continuous trademark protection
Get notified about every new filing that threatens ABYLQIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.